documents: FDA-2001-D-0219-0016
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2001-D-0219-0016 | FDA | FDA-2001-D-0219 | Use of Data Monitoring Committees in Clinical Trials; Guidance for Industry; Draft Guidance | Other | Guidance | 2024-02-13T05:00:00Z | 2024 | 2 | 2024-02-13T05:00:00Z | 2024-04-16T03:59:59Z | 2025-06-06T09:00:07Z | 1 | 0 | 0900006486404548 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref